Search research articles
Contact Us
Filters
Showing results (31-40 of 72) with videos related to
Page
of 8
Sort By:
International Journal of Hematology
|
March 15, 2006
Myelodysplastic syndrome
Shinji Nakao, H Joachim Deeg, Takayuki Ishikawa, et al.
Annals of Hematology
|
September 11, 2013
Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomes
Aristoteles Giagounidis, Ghulam J Mufti, Pierre Fenaux, et al.
Leukemia Research
|
March 2, 2016
T-cell large granular lymphocyte proliferation in myelodysplastic syndromes: Clinicopathological features and prognostic significance
Xiaohui Zhang, Lubomir Sokol, John M Bennett, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 7, 2015
Lenalidomide Treatment for Lower Risk Nondeletion 5q Myelodysplastic Syndromes Patients Yields Higher Response Rates When Used Before Azacitidine
Amer M Zeidan, Najla H Al Ali, Eric Padron, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 14, 2016
Immunosuppressive Therapy: Exploring an Underutilized Treatment Option for Myelodysplastic Syndrome
Mintallah Haider, Najla Al Ali, Eric Padron, et al.
American Journal of Hematology
|
March 25, 2015
WT1 vaccination in AML and MDS: A pilot trial with synthetic analog peptides
Jason Brayer, Jeffrey E Lancet, John Powers, et al.
Cancer
|
March 17, 2007
The incidence and impact of thrombocytopenia in myelodysplastic syndromes
Hagop Kantarjian, Francis Giles, Alan List, et al.
Journal of the National Cancer Institute
|
October 30, 2008
Characteristics of US patients with myelodysplastic syndromes: results of six cross-sectional physician surveys
Mikkael A Sekeres, W Marieke Schoonen, Hagop Kantarjian, et al.
Molecular Cancer Therapeutics
|
April 14, 2007
Dasatinib (BMS-354825) inhibits Stat5 signaling associated with apoptosis in chronic myelogenous leukemia cells
Sangkil Nam, Ann Williams, Adina Vultur, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 23, 2015
Validation of the Lower-Risk MD Anderson Prognostic Scoring System for Patients With Myelodysplastic Syndrome
Rami Komrokji, Hanadi Ramadan, Najla Al Ali, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 72) with videos related to
Sort By:
Page
of 8
International Journal of Hematology
|
March 15, 2006
Myelodysplastic syndrome
Shinji Nakao, H Joachim Deeg, Takayuki Ishikawa, et al.
Annals of Hematology
|
September 11, 2013
Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomes
Aristoteles Giagounidis, Ghulam J Mufti, Pierre Fenaux, et al.
Leukemia Research
|
March 2, 2016
T-cell large granular lymphocyte proliferation in myelodysplastic syndromes: Clinicopathological features and prognostic significance
Xiaohui Zhang, Lubomir Sokol, John M Bennett, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 7, 2015
Lenalidomide Treatment for Lower Risk Nondeletion 5q Myelodysplastic Syndromes Patients Yields Higher Response Rates When Used Before Azacitidine
Amer M Zeidan, Najla H Al Ali, Eric Padron, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 14, 2016
Immunosuppressive Therapy: Exploring an Underutilized Treatment Option for Myelodysplastic Syndrome
Mintallah Haider, Najla Al Ali, Eric Padron, et al.
American Journal of Hematology
|
March 25, 2015
WT1 vaccination in AML and MDS: A pilot trial with synthetic analog peptides
Jason Brayer, Jeffrey E Lancet, John Powers, et al.
Cancer
|
March 17, 2007
The incidence and impact of thrombocytopenia in myelodysplastic syndromes
Hagop Kantarjian, Francis Giles, Alan List, et al.
Journal of the National Cancer Institute
|
October 30, 2008
Characteristics of US patients with myelodysplastic syndromes: results of six cross-sectional physician surveys
Mikkael A Sekeres, W Marieke Schoonen, Hagop Kantarjian, et al.
Molecular Cancer Therapeutics
|
April 14, 2007
Dasatinib (BMS-354825) inhibits Stat5 signaling associated with apoptosis in chronic myelogenous leukemia cells
Sangkil Nam, Ann Williams, Adina Vultur, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 23, 2015
Validation of the Lower-Risk MD Anderson Prognostic Scoring System for Patients With Myelodysplastic Syndrome
Rami Komrokji, Hanadi Ramadan, Najla Al Ali, et al.
Page
of 8